Prague Med. Rep. 2013, 114, 239-245
https://doi.org/10.14712/23362936.2014.13
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Patients with Chronic Hepatitis B
References
1. Acar, G., Yorgun, H., Inci, M. F., Akkoyun, M., Bakan, B., Nacar, A. B., Dirnak, I., Cetin, G. Y., Bozoglan, O. (2013) Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod. Rheumatol. (Epub ahead of print)
2. , A., Davoodi, G., Boroumand, M. A., Darabyan, S., Dehkordi, M. R., Goodarzynejad, H. (2007) Association between hepatitis B surface antibody seropositivity and coronary artery disease. Indian J. Med. Sci. 61, 648–655.
3. , C., Shimizu, W., Yan, G. X., Sicouri, S. (1998) Cellular basis for QT dispersion. J. Electrocardiol. 30, 168–175.
<https://doi.org/10.1016/S0022-0736(98)80070-8>
4. , C., Sicouri, S., Di Diego, J. M., Burashnikov, A., Viskin, S., Shimizu, W., Yan, G. X., Kowey, P., Zhang, L. (2007) Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 4, 1114–1116.
<https://doi.org/10.1016/j.hrthm.2007.05.028>
<PubMed>
5. Hevia, J., Antzelevitch, C., Tornés Bárzaga, F., Dorantes Sánchez, M., Dorticós Balea, F., Zayas Molina, R., Quiñones Pérez, M. A., Fayad Rodríguez, Y. (2006) Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J. Am. Coll. Cardiol. 47, 1828–1834.
<https://doi.org/10.1016/j.jacc.2005.12.049>
<PubMed>
6. , C. P., McComb, J. M., Campbell, R. W. (1990) QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br. Heart J. 63, 342–344.
<https://doi.org/10.1136/hrt.63.6.342>
<PubMed>
7. , M., Demir, C. (2012a) Effect of hepatitis B virus infection on the autonomic dysfunction. HealthMed 6, 2355–2358.
8. , M., Demir, C. (2012b) Effect of hepatitis B virus infection on right and left ventricular functions. Med. Sci. Monit. 18, CR587–CR591.
<https://doi.org/10.12659/MSM.883356>
<PubMed>
9. Demir, M., Uyan, U. (2013) Evaluation of Tp-e interval and Tp-e/QT ratio in patients with non-dipper hypertension. Clin. Exp. Hypertens. (Epub ahead of print)
10. , G. (2003) Natural history and prognosis of hepatitis B. Semin. Liver Dis. 23, 47–58.
<https://doi.org/10.1055/s-2003-37590>
11. , J., Newton, J. L. (2009) Autonomic dysfunction in chronic liver disease. Liver Int. 29, 483–489.
<https://doi.org/10.1111/j.1478-3231.2009.01985.x>
12. , P., Patel, C., Patel, H., Narayanaswamy, S., Malhotra, B., Green, J. T., Yan, G. X. (2008) T(p-e)/QT ratio as an index of arrhythmogenesis. J. Electrocardiol. 41, 567–574.
<https://doi.org/10.1016/j.jelectrocard.2008.07.016>
13. , J. A., Ritsema van Eck, H. J., van Herpen, G. (2008) The meaning of the Tp-Te interval and its diagnostic value. J. Electrocardiol. 41, 575–580.
<https://doi.org/10.1016/j.jelectrocard.2008.07.030>
14. , M., Ata, N., Yavuz, B., Dal, K., Ertugrul, D. T., Yalcin, A. A., Deveci, O. S., Sen, O., Akin, K. O., Cizmeci, Z., Sacikara, M., Nazligul, Y. (2012) Elevation of B-type natriuretic peptide level in asymptomatic hepatitis B virus-positive patients is not associated with abnormalities of cardiac function. Med. Princ. Pract. 21, 150–155.
<https://doi.org/10.1159/000332440>
15. , D. (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11, 97–107.
<https://doi.org/10.1046/j.1365-2893.2003.00487.x>
16. , A. (2001) Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus. Intern. Med. 40, 182–184.
<https://doi.org/10.2169/internalmedicine.40.182>
17. , A., Ohashi, N., Hasegawa, K., Sasayama, S., Eto, T., Imaizumi, T., Izumi, T., Kawamura, K., Kawana, M., Kimura, A., Kitabatake, A., Matsuzaki, M., Nagai, R., Tanaka, H., Hiroe, M., Hori, M., Inoko, H., Seko, Y., Sekiguchi, M., Shimotohno, K., Sugishita, Y., Takeda, N., Takihara, K., Tanaka, M., Yokoyama, M. (1998) Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Jpn. Circ. J. 62, 389–391.
<https://doi.org/10.1253/jcj.62.389>
18. , J., Horváth, T., Abonyi, M., Tóth, T., Visnyei, Z., Bekö, G., Csák, T., Lakatos, P. L., Littvay, L., Fehér, J., Kempler, P., Kollai, M., Szalay, F. (2009) Chronic hepatitis C virus infection associated with autonomic dysfunction. Liver Int. 29, 1473–1478.
<https://doi.org/10.1111/j.1478-3231.2009.02075.x>
19. , Q., Huang, J., Su, E., Li, J., Li, J., Zhanget, L., Cao, K. (2007) Infection of hepatitis B virus in extrahepatic endothelial tissues mediated by endothelial progenitor cells. Virol. J. 4, 36–40.
<https://doi.org/10.1186/1743-422X-4-36>
<PubMed>
20. , P., Schmidt, A., Zabel, M., Hnatkova, K., Franz, M., Huber, K., Malik, M. (2011) Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components. J. Electrocardiol. 44, 301–308.
<https://doi.org/10.1016/j.jelectrocard.2011.03.004>
21. , L., Geng, J., Li, J., Li, T., Matsumori, A., Chang, Y., Lu, F., Zhuang, H. (2011) The biomarker N-terminal pro-brain natriuretic peptide and liver diseases. Clin. Invest. Med. 34, E30–E37.
<https://doi.org/10.25011/cim.v34i1.14910>
22. , R., Sabin, C., Reiss, P., de Wit, S., Worm, S. W., Law, M., Dabis, F., D’Arminio Monforte, A., Fontas, E., El-Sadr, W., Kirk, O., Rickenbach, M., Phillips, A., Ledergerber, B., Lundgren, J., Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group (2010) HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study. Antivir. Ther. 15, 1077–1086.
23. , X., Xie, Z., Chu, Y., Yang, L., Xu, W., Yang, X., Liu, X., Tian, L. (2012) Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin. Cardiol. 35, 559–564.
<https://doi.org/10.1002/clc.22022>
<PubMed>
